Export 2722 results:
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
V
M. M. Venkatesan, Ballou, C., Barnoy, S., McNeal, M., El-Khorazaty, J., Frenck, R., and Baqar, S., “Antibody in Lymphocyte Supernatant (ALS) responses after oral vaccination with live Shigella sonnei vaccine candidates WRSs2 and WRSs3 and correlation with serum antibodies, ASCs, fecal IgA and shedding.”, PLoS One, vol. 16, no. 11, p. e0259361, 2021.
L. E. Via, Gore-Langton, R. E., and Pluda, J. M., “Clinical trials referral resource. Current clinical trials administering the antiangiogenesis agent SU5416”, Oncology, vol. 14, pp. 13121315-16 1321-23, 2000.
L. E. Via, Gore-Langton, R. E., and Pluda, J. M., “Clinical trials referral resource. Current clinical trials administering the antiangiogenesis agent SU5416.”, Oncology (Williston Park), vol. 14, no. 9, pp. 1312, 1315-6, 1321-3, 2000.
A. Vigano, Vella, S., Saresella, M., Vanzulli, A., Bricalli, D., Di Fabio, S., Ferrante, P., Andreotti, M., Pirillo, M., Dally, L. G., Clerici, M., and Principi, N., “Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volume”, AIDS Res HumRetroviruses, vol. 14, pp. 251-61, 2000.
A. Vigano, Dally, L., Bricalli, D., Sala, N., Pirillo, M., Saresella, M., Trabattoni, D., Vella, S., Clerici, M., and Principi, N., “Clinical and immuno-virologic characterization of the efficacy of stavudine, lamivudine, and indinavir in human immunodeficiency virus infection”, J Pediatric, vol. 135, pp. 675-82, 1999.
A. Vigano, Vella, S., Saresella, M., Vanzulli, A., Bricalli, D., Di Fabio, S., Ferrante, P., Andreotti, M., Pirillo, M., Dally, L. G., Clerici, M., and Principi, N., “Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volume.”, AIDS, vol. 14, no. 3, pp. 251-61, 2000.
A. Vigano, Dally, L., Bricalli, D., Sala, N., Pirillo, M., Saresella, M., Trabattoni, D., Vella, S., Clerici, M., and Principi, N., “Clinical and immuno-virologic characterization of the efficacy of stavudine, lamivudine, and indinavir in human immunodeficiency virus infection.”, J Pediatr, vol. 135, no. 6, pp. 675-82, 1999.
L. Vignati, Sheetz, M. J., Girach, A., Zhi, X., Davis, M. D., Milton, R. C., and Group, Afor the P. K., “Effect of the oral protein kinase C b Inhibitor, Ruboxistaurin, on visual acuity in the PKC-DRS2 Study”, 2006.
S. Vitale, Clemons, T. E., Agrón, E., Ferris, F. L., Domalpally, A., Danis, R. P., and Chew, E. Y., “Evaluating the Validity of the Age-Related Eye Disease Study Grading Scale for Age-Related Macular Degeneration: AREDS2 Report 10.”, JAMA Ophthalmol, vol. 134, no. 9, pp. 1041-7, 2016.
S. Vitale, Agrón, E., Clemons, T. E., Keenan, T. D. L., Domalpally, A., Danis, R. P., and Chew, E. Y., “Association of 2-Year Progression Along the AREDS AMD Scale and Development of Late Age-Related Macular Degeneration or Loss of Visual Acuity: AREDS Report 22.”, JAMA Ophthalmol, 2020.
A. Vora, SanGiovanni, J. P., Chew, E. Y., Ajudua, S. N., Reed, G. F., Agron, E., Henning, A. K., Clemons, T. E., Hoh, J., and Elashoff, M., “Single Marker Associations of Cell Cycle Pathway Genes with Advanced AMD”, in Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 2007.
J. M. Vose, Carter, S., Burns, L. J., Ayala, E., Press, O. W., Moskowitz, C. H., Stadtmauer, E. A., Mineshi, S., Ambinder, R., Fenske, T., Horowitz, M., Fisher, R., and Tomblyn, M., “Phase III randomized study of rituximab/carmustine, etoposide, cytarabine, and melphalan (BEAM) compared with iodine-131 tositumomab/BEAM with autologous hematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: results from the BMT C”, J Clin Oncol, vol. 31, no. 13, pp. 1662-8, 2013.
W
J. W, FN, N., O, A., G, O. Manyonyi, J, B., A, N., F, B., K, B., H, O., S, W., L, M., W, W., J, O., M, O., J, I., J, N. - A., C, K., ,, Smith, C., Barin, B., Dally, L., ,, and Kaleebu, P., “Safety and Immunogenicity of Recombinant Low-Dosage HIV-1 A Vaccine Candidates Vectored by Plasmid pTHr DNA or Modified Vaccinia Virus Ankara (MVA) in Humans in East Africa”, Vaccine, vol. 26, pp. 2788-2795, 2008.
J. E. Wagner, Eapen, M., Carter, S. L., Haut, P., Peres, E., Schultz, K. R., Thompson, J., Wall, D., and Kurtzberg, J., “Lack of Enhanced Survival after Double Umbilical Cord Blood (UCB) Transplant Compared to Single UCB Transplant in Children with Hematological Malignancy: Results of the BMT-CTN Randomized Trial”, in 54th Annual ASH Meeting, Atlanta, GA, 2012.
J. Wagner, Thompson, J., Carter, S. L., Jensen, L., and Kernan, N., “Impact of Graft-Versus-Host Disease (GVHD) Prophylaxis on 3-Year Disease-Free Survival (DFS): Results of a Multi-Center, Randomized Phase II-III Trial Comparing T Cell Depletion/Cyclosporine (TCD) and Methotrexate/Cyclosporine (M/C) in 410 Recipients of U”, 2002.
E. L. Wagner, Brock, K. L., and Carter, S. L., “The Cord Blood Transplantation (COBLT) Study: An internet data system for the COBLT Study Cord Blood Banks”, 1999.
J. E. Wagner, Eapen, M., Carter, S., Wang, Y., Schultz, K. R., Wall, D. A., Bunin, N., Delaney, C., Haut, P., Margolis, D., Peres, E., Verneris, M. R., Walters, M., Horowitz, M. M., and Kurtzberg, J., “One-unit versus two-unit cord-blood transplantation for hematologic cancers.”, N Engl J Med, vol. 371, no. 18, pp. 1685-94, 2014.
A. Wahle, “Variation in substance use screening outcomes with commonly used screening strategies in primary care: Findings from a multi-site implementation study of electronic health record-integrated screening for alcohol and drug use”. 2020.
T. Waid, Holman, M., Mulloy, L., Shihab, F., Conti, D., DeMatos, A., Freeman, R., Jensik, S., Francos, G., Jordan, S., Van Buren, D., Basadonna, G., Chan, L., Steiner, R., Brinker, K., Steinberg, S., Matas, A., Burrows, L., Cohen, D., Inokuchi, S., Kasiske, B., Pirsch, J., and , “Untitled”, 2001.
S. Waldstein, Lefkowitz, D., Siegel, E., Rosenberger, W., Spencer, R., Tankard, C., Manukyan, Z., Gerber, E., Lodge, M., and Katzel, M., “Reduced Cerebral Blood Flow in Older Men with Higher Levels of Blood Pressure”, Journal of Hypertension, vol. 28, pp. 993-998, 2010.
S. R. Waldstein, Lefkowitz, D. M., Siegel, E. L., Rosenberger, W. F., Spencer, R. J., Tankard, C. F., Manukyan, Z., Gerber, E. J., and Katzel, L., “Reduced cerebral blood flow in older men with higher levels of blood pressure.”, J Hypertens, vol. 28, no. 5, pp. 993-8, 2010.
J. M. Walker, Mulatya, C., Hebert, D., Wilson, S. H., Lindblad, A. S., and Weaver, L. K., “Sleep assessment in a randomized trial of hyperbaric oxygen in U.S. service members with post concussive mild traumatic brain injury compared to normal controls.”, Sleep Med, vol. 51, pp. 66-79, 2018.
D. Wall, Carter, S. L., Kapoor, N., Kamani, N., Kernan, N., Jensen, L., Brochstein, J., Frangoul, H., Goyal, R., Horan, J., Pietryga, D., Wagner, J., and Kurtzberg, J., “Busulfan/melphalan/ATG (Bu/Mel/ATG) as a preparative regimen for unrelated donor cord blood transplantation (UCBT): the COBLT experience”, 2003.
E. K. Waller, Logan, B. R., Harris, W. A. C., Devine, S. M., Porter, D. L., Mineishi, S., McCarty, J. M., Gonzalez, C. E., Spitzer, T. R., Krijanovski, O. I., Linenberger, M. L., Woolfrey, A., Howard, A., Wu, J., Confer, D. L., and Anasetti, C., “Improved survival after transplantation of more donor plasmacytoid dendritic or naïve T cells from unrelated-donor marrow grafts: results from BMTCTN 0201.”, J Clin Oncol, vol. 32, no. 22, pp. 2365-72, 2014.
E. K. Waller, Harris, W. A., Devine, S., Porter, D. L., Ferrara, J., McCarthy, J. M., Gonzalez, C. E., Spitzer, T. R., Krijanovski, O., Howard, A., Gurgol, C., Logan, B., Confer, D. L., and Anasetti, C., “Grade III - IV Acute GvHD and Treatment-Related Mortality Are Reduced Among Recipients of Larger Numbers of Donor Naïve CD8+ T-cells and Plasmacytoid Dendritic Cell Precursors in Allogeneic BM Grafts from Unrelated Donors: Results from BMT CTN 0201”, in 38th Annual EBMT (European Group for Blood and Marrow Transplantation), Geneva, Switzerland, 2012.